CoChat

Joint genome-wide association study of progressive supranuclear palsy identifies novel susceptibility loci and genetic correlation to neurodegenerative diseases

Open access
Chen, Jason A., Chen, Zhongbo, Won, Hyejung, Huang, Alden Y., Lowe, Jennifer K., Wojta, Kevin, Yokoyama, Jennifer S., Bensimon, Gilbert, Leigh, P. Nigel, Payan, Christine, Shatunov, Aleksey, Jones, Ashley R., Lewis, Cathryn M., Deloukas, Panagiotis, Amouyel, Philippe, Tzourio, Christophe, Dartigues, Jean-Francois, Ludolph, Albert, Boxer, Adam L., Bronstein, Jeff M., Al-Chalabi, Ammar, Geschwind, Daniel H., Coppola, Giovanni · 2018 · Molecular Neurodegeneration
Cited by 116

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Abstract

Progressive supranuclear palsy (PSP) is a rare neurodegenerative disease for which the genetic contribution is incompletely understood. We conducted a joint analysis of 5,523,934 imputed SNPs in two newly-genotyped progressive supranuclear palsy cohorts, primarily derived from two clinical trials (Allon davunetide and NNIPPS riluzole trials in PSP) and a previously published genome-wide association study (GWAS), in total comprising 1646 cases and 10,662 controls of European ancestry. We identified 5 associated loci at a genome-wide significance threshold P < 5 × 10 − 8 , including replication of 3 loci from previous studies and 2 novel loci at 6p21.1 and 12p12.1 (near RUNX2 and SLCO1A2 , respectively). At the 17q21.31 locus, stepwise regression analysis confirmed the presence of multiple independent loci (localized near MAPT and KANSL1 ). An additional 4 loci were highly suggestive of association ( P < 1 × 10 − 6 ). We analyzed the genetic correlation with multiple neurodegenerative diseases, and found that PSP had shared polygenic heritability with Parkinson’s disease and amyotrophic lateral sclerosis. In total, we identified 6 additional significant or suggestive SNP associations with PSP, and discovered genetic overlap with other neurodegenerative diseases. These findings clarify the pathogenesis and genetic architecture of PSP.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13024-018-0270-8

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Research works printed but not linked: 23

  1. Respondek G, Roeber S, Kretzschmar H, Troakes C, Al-Sarraj S, Gelpi E, Gaig C, Chiu WZ, van Swieten JC, Oertel WH, et al. Accuracy of the national institute for neurological disorders and stroke/society for progressive supranuclear palsy and neuroprotection and natural history in Parkinson plus syndromes criteria for the diagnosis of progressive supranuclear palsy. Mov Disord. 2013;28(4):504–9. · DOI · Paper page
  2. Chen JA, Wang Q, Davis-Turak J, et al. A multiancestral genome-wide exome array study of alzheimer disease, frontotemporal dementia, and progressive supranuclear palsy. JAMA Neurol. 2015;72(4):414–22. · DOI · Paper page
  3. Williams DR, de Silva R, Paviour DC, Pittman A, Watt HC, Kilford L, Holton JL, Revesz T, Lees AJ. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain. 2005;128(6):1247–58. · DOI · Paper page
  4. Josephs KA, Petersen RC, Knopman DS, Boeve BF, Whitwell J, Duffy JR, Parisi JE, Dickson DW. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology. 2006;66(1):41–8. · DOI · Paper page
  5. Osaki Y, Ben-Shlomo Y, Lees AJ, Daniel SE, Colosimo C, Wenning G, Quinn N. Accuracy of clinical diagnosis of progressive supranuclear palsy. Mov Disord. 2004;19(2):181–9. · DOI · Paper page
  6. Bensimon G, Ludolph A, Agid Y, Vidailhet M, Payan C, Leigh PN. Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study. Brain. 2009;132(1):156–71. · DOI · Paper page
  7. Hoglinger GU, Melhem NM, Dickson DW, Sleiman PMA, Wang L-S, Klei L, Rademakers R, de Silva R, Litvan I, Riley DE, et al. Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat Genet. 2011;43(7):699–705. · DOI · Paper page
  8. Li Y, Chen JA, Sears RL, Gao F, Klein ED, Karydas A, Geschwind MD, Rosen HJ, Boxer AL, Guo W, et al. An epigenetic signature in peripheral blood associated with the haplotype on 17q21.31, a risk factor for neurodegenerative Tauopathy. PLoS Genet. 2014;10(3):e1004211. · DOI · Paper page
  9. Rosenbloom KR, Armstrong J, Barber GP, Casper J, Clawson H, Diekhans M, Dreszer TR, Fujita PA, Guruvadoo L, Haeussler M, et al. The UCSC genome browser database: 2015 update. Nucleic Acids Res. 2015;43(D1):D670–81. · DOI · Paper page
  10. Delaneau O, Marchini J. The genomes project C: integrating sequence and array data to create an improved 1000 genomes project haplotype reference panel. Nat Commun. 2014;5:3934. · DOI · Paper page
  11. Turner SD. qqman: an R package for visualizing GWAS results using Q-Q and manhattan plots. In: bioRxiv; 2014. p. 005165. https://doi.org/10.1101/005165 . · DOI · Paper page
  12. Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36(3):48. · DOI · Paper page
  13. Freedman ML, Reich D, Penney KL, McDonald GJ, Mignault AA, Patterson N, Gabriel SB, Topol EJ, Smoller JW, Pato CN, et al. Assessing the impact of population stratification on genetic association studies. Nat Genet. 2004;36(4):388–93. · DOI · Paper page
  14. Schrag A, Ben-Shlomo Y, Quinn NP. Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. Lancet. 1999;354(9192):1771–5. · DOI · Paper page
  15. Nath U, Ben-Shlomo Y, Thomson RG, Morris HR, Wood NW, Lees AJ, Burn DJ. The prevalence of progressive supranuclear palsy (Steele–Richardson–Olszewski syndrome) in the UK. Brain. 2001;124(7):1438–49. · DOI · Paper page
  16. Yang J, Lee SH, Goddard ME, Visscher PM. GCTA: a tool for genome-wide complex trait analysis. Am J Hum Genet. 2011;88(1):76–82. · DOI · Paper page
  17. Yang J, Weedon MN, Purcell S, Lettre G, Estrada K, Willer CJ, Smith AV, Ingelsson E, O'Connell JR, Mangino M, et al. Genomic inflation factors under polygenic inheritance. Eur J Hum Genet. 2011;19(7):807–12. · DOI · Paper page
  18. Chen J, Yu J-T, Wojta K, Wang H-F, Zetterberg H, Blennow K, Yokoyama JS, Weiner MW, Kramer JH, Rosen H, et al. Genome-wide association study identifies MAPT locus influencing human plasma tau levels. Neurology. 2017;88(7):669–76. · DOI · Paper page
  19. Komori T. Regulation of bone development and extracellular matrix protein genes by RUNX2. Cell Tissue Res. 2009;339(1):189–95. · DOI · Paper page
  20. Urquhart BL, Kim RB. Blood−brain barrier transporters and response to CNS-active drugs. Eur J Clin Pharmacol. 2009;65(11):1063–70. · DOI · Paper page
  21. Legati A, Giovannini D, Nicolas G, Lopez-Sanchez U, Quintans B, Oliveira JRM, Sears RL, Ramos EM, Spiteri E, Sobrido M-J, et al. Mutations in XPR1 cause primary familial brain calcification associated with altered phosphate export. Nat Genet. 2015;47(6):579–81. · DOI · Paper page
  22. Nalls MA, Keller MF, Hernandez DG, Chen L, Stone DJ, Singleton AB. On behalf of the Parkinson’s progression marker initiative i: baseline genetic associations in the Parkinson’s progression markers initiative (PPMI). Mov Disord. 2016;31(1):79–85. · DOI
  23. van Rheenen W, Shatunov A, Dekker AM, McLaughlin RL, Diekstra FP, Pulit SL, van der Spek RAA, Vosa U, de Jong S, Robinson MR, et al. Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis. Nat Genet. 2016;48(9):1043–8. · DOI · Paper page

Cited by

See all 116

Metadata

Authors
Chen, J. A., Chen, Z., Won, H., Huang, A. Y., Lowe, J. K., Wojta, K., Yokoyama, J. S., Bensimon, G., Leigh, P. N., Payan, C., Shatunov, A., Jones, A. R., Lewis, C. M., Deloukas, P., Amouyel, P., Tzourio, C., Dartigues, J.-F., Ludolph, A., Boxer, A. L., Bronstein, J. M., Al-Chalabi, A., Geschwind, D. H., & Coppola, G.
Venue
Molecular Neurodegeneration
Published
2018-08-08
Volume
13
Issue
1
Pages
41-41
ISSN
1750-1326 (ISSN-L)
OpenAlex
W2883236199
Cited by
116
References
22
FWCI
5.78
Type
journal article
Language
en
Open access
gold
Licence
creativecommons.org/licenses/by/4.0/ (tdm)
Funders
National Institute of Neurological Disorders and Stroke (F31 NS084556)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Joint genome-wide association study of progressive supranuclear palsy identifies novel susceptibility loci and genetic correlation to neurodegenerative diseases. https://app.cochat.ai/papers/10.1186/s13024-018-0270-8
The paper
Chen, J. A., Chen, Z., Won, H., Huang, A. Y., Lowe, J. K., Wojta, K., Yokoyama, J. S., Bensimon, G., Leigh, P. N., Payan, C., Shatunov, A., Jones, A. R., Lewis, C. M., Deloukas, P., Amouyel, P., Tzourio, C., Dartigues, J.-F., Ludolph, A., Boxer, A. L., . . . Coppola, G. (2018). Joint genome-wide association study of progressive supranuclear palsy identifies novel susceptibility loci and genetic correlation to neurodegenerative diseases. Molecular Neurodegeneration. https://doi.org/10.1186/s13024-018-0270-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.